101 related articles for article (PubMed ID: 16314485)
1. Heterogeneity of Tie2 expression in tumor microcirculation: influence of cancer type, implantation site, and response to therapy.
Fathers KE; Stone CM; Minhas K; Marriott JJ; Greenwood JD; Dumont DJ; Coomber BL
Am J Pathol; 2005 Dec; 167(6):1753-62. PubMed ID: 16314485
[TBL] [Abstract][Full Text] [Related]
2. Tie2/TEK modulates the interaction of glioma and brain tumor stem cells with endothelial cells and promotes an invasive phenotype.
Liu D; Martin V; Fueyo J; Lee OH; Xu J; Cortes-Santiago N; Alonso MM; Aldape K; Colman H; Gomez-Manzano C
Oncotarget; 2010 Dec; 1(8):700-709. PubMed ID: 21321379
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of Tie2 gene by a novel antitumor sulfolipid, 3'-sulfoquinovosyl-1'-monoacylglycerol, targeting angiogenesis.
Mori Y; Sahara H; Matsumoto K; Takahashi N; Yamazaki T; Ohta K; Aoki S; Miura M; Sugawara F; Sakaguchi K; Sato N
Cancer Sci; 2008 May; 99(5):1063-70. PubMed ID: 18380795
[TBL] [Abstract][Full Text] [Related]
4. Identification of a characteristic vascular belt zone in human colorectal cancer.
Kather JN; Zöllner FG; Schad LR; Melchers SM; Sinn HP; Marx A; Gaiser T; Weis CA
PLoS One; 2017; 12(3):e0171378. PubMed ID: 28253263
[TBL] [Abstract][Full Text] [Related]
5. Anti-angiogenesis revisited: reshaping the treatment landscape of advanced non-small cell lung cancer.
Choi SH; Yoo SS; Lee SY; Park JY
Arch Pharm Res; 2022 Apr; 45(4):263-279. PubMed ID: 35449345
[TBL] [Abstract][Full Text] [Related]
6. Glomerular endothelial cell heterogeneity in Alport syndrome.
Soloyan H; Thornton M; Villani V; Khatchadourian P; Cravedi P; Angeletti A; Grubbs B; De Filippo R; Perin L; Sedrakyan S
Sci Rep; 2020 Jul; 10(1):11414. PubMed ID: 32651395
[TBL] [Abstract][Full Text] [Related]
7. Identification of LPS-Activated Endothelial Subpopulations With Distinct Inflammatory Phenotypes and Regulatory Signaling Mechanisms.
Dayang EZ; Plantinga J; Ter Ellen B; van Meurs M; Molema G; Moser J
Front Immunol; 2019; 10():1169. PubMed ID: 31178871
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Value of the Combination of Low VEGFR-1 and High VEGFR-2 Expression in Endothelial Cells of Colorectal Cancer.
D'Haene N; Koopmansch C; Van Eycke YR; Hulet F; Allard J; Bouri S; Rorive S; Remmelink M; Decaestecker C; Maris C; Salmon I
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30423986
[TBL] [Abstract][Full Text] [Related]
9. Targeting Tie-2/angiopoietin axis in experimental mesothelioma confers differential responses and raises predictive implications.
Magkouta S; Pappas A; Pateras IS; Kollintza A; Moschos C; Vazakidou ME; Karavana V; Gorgoulis VG; Kalomenidis I
Oncotarget; 2018 Apr; 9(31):21783-21796. PubMed ID: 29774102
[TBL] [Abstract][Full Text] [Related]
10. Acidic pH reduces VEGF-mediated endothelial cell responses by downregulation of VEGFR-2; relevance for anti-angiogenic therapies.
Faes S; Uldry E; Planche A; Santoro T; Pythoud C; Demartines N; Dormond O
Oncotarget; 2016 Dec; 7(52):86026-86038. PubMed ID: 27852069
[TBL] [Abstract][Full Text] [Related]
11. Matricellular protein SPARCL1 regulates tumor microenvironment-dependent endothelial cell heterogeneity in colorectal carcinoma.
Naschberger E; Liebl A; Schellerer VS; Schütz M; Britzen-Laurent N; Kölbel P; Schaal U; Haep L; Regensburger D; Wittmann T; Klein-Hitpass L; Rau TT; Dietel B; Méniel VS; Clarke AR; Merkel S; Croner RS; Hohenberger W; Stürzl M
J Clin Invest; 2016 Nov; 126(11):4187-4204. PubMed ID: 27721236
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of Tie2 receptor and VEGFR2 by endothelial clones derived from isolated bovine mononuclear cells.
Adamcic U; Yurkiewich A; Coomber BL
PLoS One; 2012; 7(12):e53385. PubMed ID: 23300924
[TBL] [Abstract][Full Text] [Related]
13. Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling.
Felcht M; Luck R; Schering A; Seidel P; Srivastava K; Hu J; Bartol A; Kienast Y; Vettel C; Loos EK; Kutschera S; Bartels S; Appak S; Besemfelder E; Terhardt D; Chavakis E; Wieland T; Klein C; Thomas M; Uemura A; Goerdt S; Augustin HG
J Clin Invest; 2012 Jun; 122(6):1991-2005. PubMed ID: 22585576
[TBL] [Abstract][Full Text] [Related]
14. Crk adaptor proteins act as key signaling integrators for breast tumorigenesis.
Fathers KE; Bell ES; Rajadurai CV; Cory S; Zhao H; Mourskaia A; Zuo D; Madore J; Monast A; Mes-Masson AM; Grosset AA; Gaboury L; Hallet M; Siegel P; Park M
Breast Cancer Res; 2012 May; 14(3):R74. PubMed ID: 22569336
[TBL] [Abstract][Full Text] [Related]
15. Endothelial cell heterogeneity.
Aird WC
Cold Spring Harb Perspect Med; 2012 Jan; 2(1):a006429. PubMed ID: 22315715
[TBL] [Abstract][Full Text] [Related]
16. Lack of efficacy of combined antiangiogenic therapies in xenografted human melanoma.
Adamcic U; Castagna C; Minhas K; Shahrzad S; Coomber BL
J Oncol; 2012; 2012():794172. PubMed ID: 22007215
[TBL] [Abstract][Full Text] [Related]
17. VEGFR2 heterogeneity and response to anti-angiogenic low dose metronomic cyclophosphamide treatment.
Patten SG; Adamcic U; Lacombe K; Minhas K; Skowronski K; Coomber BL
BMC Cancer; 2010 Dec; 10():683. PubMed ID: 21159176
[TBL] [Abstract][Full Text] [Related]
18. Molecular photoacoustic imaging of angiogenesis with integrin-targeted gold nanobeacons.
Pan D; Pramanik M; Senpan A; Allen JS; Zhang H; Wickline SA; Wang LV; Lanza GM
FASEB J; 2011 Mar; 25(3):875-82. PubMed ID: 21097518
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of vascular and progenitor cell compartments in tumours from MMTV-PyVmT transgenic mice during mammary cancer progression.
Smith MJ; Berger RW; Minhas K; Moorehead RA; Coomber BL
Int J Exp Pathol; 2011 Apr; 92(2):106-16. PubMed ID: 21059124
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of resistance to tumour anti-angiogenic strategies.
Grépin R; Pagès G
J Oncol; 2010; 2010():835680. PubMed ID: 20224655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
